Our data demonstrated a significant increase in the proportion of CD16+ NK cells following NICT, suggesting the potential for NK cells to be reactivated by CD8+ T cells and to exert anti-tumor effects after applying PD-1 inhibitors. Here, CD8A is linked to neoplasm.